Wait, we have a special
offer for you!
Click the button below to get your discount.
Get my coupon now No thanks, I'd like to pay full price
Click the button below to get your discount.
Get my coupon now No thanks, I'd like to pay full price
Only Available By Prescription
A generic drug is a copy of the brand-name drug with the same dosage, safety, strength, quality, consumption method, performance, and intended use. Before generics become available on the market, the generic company must prove it has the same active ingredients as the brand-name drug and works in the same way and in the same amount of time in the body.
The only differences between generics and their brand-name counterparts is that generics are less expensive and may look slightly different (eg. different shape or color), as trademarks laws prevent a generic from looking exactly like the brand-name drug.
Generics are less expensive because generic manufacturers don't have to invest large sums of money to develop a drug. When the brand-name patent expires, generic companies can manufacture a copy of the brand-name and sell it at a substantial discount.
Fruzaqla is a colorectal cancer treatment medication available by prescription and used for patients who have had their cancer metastasize from the colon. Fruquintinib is an oral kinase inhibitor class drug that blocks VEGFR vascular endothelial proteins that the tumor needs to grow, and it also works to deprive the cancerous cells of oxygen. This medication will be used as part of a targeted cancer therapy approach for metastasized colon cancer treatment. Buy Fruzaqla from Canada and Canpharm and get the best Fruzaqla price.
| Fact Table | |
|---|---|
| Formula | C21H19N3O5 |
| License | US DailyMed |
| Bioavailability | high oral bioavailability |
| Legal status | Prescription drug |
| Chemical Name | Fruquintinib |
| Elimination half-life | 42h |
| Dosage (Strength) | 1mg, 5mg |
| Pregnancy | Consult a doctor |
| Brands | Fruzaqla |
| Protein binding | 95% |
| PubChem CID | 44480399 |
| MedlinePlus | a623060 |
| ChEBI | 229221 |
| ATC code | L01EK04 |
| DrugBank | DB11679 |
| KEGG | D11977 |
| Routes of administration | By mouth |
The standard dosage for Fruzaqla is to take the medication 1x per day for 21 days (3 weeks) and then stop taking it for 7 days to complete the cycle. The length of your cycle will vary depending on your doctor's plan, and you should always take your medication precisely as indicated in your prescription.
Take Fruquintinib capsules whole and with or without food.
The active ingredient in Fruzaqla is Fruquintinib.
Let your doctor know of any history of hypertension (high blood pressure), arterial thromboembolism, gastrointestinal hemorrhaging, or liver dysfunction before starting on Fruzaqla.
This medication may increase your risk of infection or impair your wound healing ability.
Use of this medication may cause PRES encephalopathy or PPE hand-foot syndrome.
Pregnant women or women who plan to become pregnant should not use Fruzaqla unless their doctor approves it.
Store at room temperature between 68 and 77 degrees Fahrenheit.
Adverse drug interactions may occur between Fruzaqla and other Rx medications, including abrocitinib, adalimumab, alefacept, alemtuzumab, anakinra, apalutamide, azathioprine, baricitinib, bedaquiline, bimekizumab, bosentan, brentuximab, canakinumab, carbamazepine, cenobamate, certolizumab, cladribine, clofarabine, dabrafenib, daclizumab, denosumab, dexamethasone, efalizumab, efavirenz, encorafenib, enzalutamide, epirubicin, eslicarbazepine, etanercept, etrasimod, etravirine, fexinidazole, guselkumab, histoplasmin, infliximab, ixekizumab, leflunomide, lorlatinib, methotrexate, mipomersen, mitotane, modafinil, nafcillin, naltrexone, natalizumab, ocrelizumab, omacetaxine, ozanimod, pegaspargase pexidartinib, phenobarbital, phenytoin, ponesimod, remdesivir, rifapentine, rilonacept, roflumilast, sarilumab, secukinumab, siltuximab, sotorasib, teriflunomide, tildrakizumab, tocilizumab, tralokinumab, ublituximab, Upadacitinib, and voclosporin
Let your doctor know of all medications you are currently taking before getting a prescription and proceeding to buy Fruzaqla online.
Fruzaqla side effects may occur, and some users may experience diarrhea, weakness, lethargy, drowsiness, stomach or abdominal area pain, or hoarseness of the voice. If side effects are encountered, it may be best to stop use and meet with a doctor again to discuss colorectal cancer treatment medication alternatives.
What is Fruzaqla (Fruquintinib)?
Fruzaqla is a once-daily non-chemotherapy oral treatment for previously treated metastatic colorectal cancer (mCRC).
How does Fruzaqla work?
Fruzaqla works by starving tumors of nutrients and oxygen, which can stop tumor growth. It was designed to block proteins called vascular endothelial growth factor receptors (VEGFR).
What is the recommended dose of Fruzaqla?
The recommended dose of Fruzaqla is 5 mg once daily for the first 21 days followed by 7 days off treatment for each 28-day cycle.
What are the possible side effects of Fruzaqla?
The most common side effects include voice changes or hoarseness, stomach-area pain, diarrhea, and weakness.
Are there any serious side effects of Fruzaqla?
Yes, the most common serious side effects were severe bleeding (hemorrhage) and a tear in your stomach or intestinal wall (gastrointestinal perforation).
How effective is Fruzaqla?
In one clinical trial, people taking Fruzaqla lived longer (7.4 months) compared to those taking a placebo (4.8 months).
How often will my Fruzaqla treatment be monitored?
This is something you should discuss with your doctor, as it can vary based on individual circumstances.
How do I take Fruzaqla?
Fruzaqla is an oral kinase inhibitor capsule taken at home with or without food.
Is Fruzaqla safe and effective in children?
It is not known if Fruzaqla is safe and effective in children.
